Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Impact of PPIs on Spontaneous Bacterial Peritonitis

Published: Thu, 18 Oct 2018 12:00:00 EDT
In what ways might the dosages of proton pump inhibitors affect the incidence and clinical course of spontaneous bacterial peritonitis?
Liver International

Advance Care Planning in Cognitively Impaired Older Adults

Published: Thu, 18 Oct 2018 12:00:00 EDT
Advance care planning for individuals with cognitive impairment is challenging. This article provides valuable practice pointers for assessment, shared decision-making, and reimbursement.
Journal of the American Geriatrics Society

Costs Associated With Diabetes Among Adult Medicaid Enrollees

Published: Thu, 18 Oct 2018 12:00:00 EDT
This report details state-specific financial burdens of diabetes in the Medicaid population of eight states.
Preventing Chronic Disease

FDA Panel Oks Tegaserod for IBS-C in Women with Low CV Risk

Published: Wed, 17 Oct 2018 19:41:59 EDT
The Gastrointestinal Drugs Advisory Committee of the FDA recommended reintroducing tegaserod maleate for women with irritable bowel syndrome and low cardiovascular risk.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


HiFiBiO buys up H-Immune, joining forces to ‘combat cancer’

Published: Mon, 15 Oct 2018 12:53:50 +0000
HiFiBiO Therapeutics has had a busy year, as pacts and raises abound, and it’s showing no signs of slowing down as it gets its checkbook out for an unusual French spinout.

Alnylam drops early filing plan for porphyria drug givosiran

Published: Mon, 15 Oct 2018 12:38:20 +0000
Alnylam says it will wait for the final results of a phase 3 trial of acute hepatic porphyria drug givosiran before filing, rather than pressing ahead on the strength of interim results.

New York biotech snaps up Eli Lilly neuro veteran as CSO

Published: Mon, 15 Oct 2018 12:25:08 +0000
Neurological biotech Redpin Therapeutics has snagged Eli Lilly veteran David Bleakman, Ph.D., as its new chief scientific officer.

Roche puts up $125M to expand SQZ cell therapy pact

Published: Mon, 15 Oct 2018 12:12:43 +0000
Roche has committed $125 million in upfront and near-term payments to expand its partnership with SQZ Biotechnologies. The revised deal sets Roche up to work with SQZ on antigen-presenting cells designed to trigger killer T cell attacks against tumors.
Displaying results 17-20 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy